STELLA PHARMA CORPORATION's total assets for Q1 2025 were ¥5.06B, a decrease of -6.64% from the previous quarter. JP:4888 total liabilities were ¥2.01B for the fiscal quarter, a -9.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.